»
S
I
D
E
B
A
R
«
Half Chaps Youth
March 7th, 2010 by admin

Half Chaps Youth
Help, I need to know now!?

I have a 4-H shows 9 of May … His classes fun and normal hunters, jumpers and stuff. Im not staying fun in class though. Since a 4-H show, do you think would be good to use my half chaps and pink and black enrollment Jods, perhaps my rust colored ones, or should I use "" OWN CLOTHES SHOW "" "? Thank you! BTW I'm doing open WT, WT Young, and jump around once. THANKS ago 22 minutes – 4 days to respond.

I am a firm believer that if something is worth doing, even just for fun, it's worth doing well. clothing adequate tan pants, white shirt with collar, boots and field jacket navy blue or black. If not, you can ask friends of the horse and its trainer if you have any can fit you. You can go to the local tack shop, find one that does the sending (material used) and buy some fishing gear used with care to show quite cheap. If I were you, I want to know that I placed where I did for my skill, not by the color of my underwear. Most of the judges, even at a local fair place to overview. You want every possible edge over the competition. If you and the other driver have the same skill, the judge will take the one with the participation and look more professional, which has the better, instantly more acceptable English in a horse and rider.

eBay Logo  

Child's Heart Half Chaps youth kid Pink XS European $60


Child’s Heart Half Chaps youth kid Pink XS European $60


$30.00


Youth Half Chaps


Youth Half Chaps


$5.99


Child's Heart Half Chaps youth kid Pink XS European $60


Child’s Heart Half Chaps youth kid Pink XS European $60


$30.00


Child's Heart Half Chaps youth kid Blue XS European $60


Child’s Heart Half Chaps youth kid Blue XS European $60


$30.00


Child's Heart Half Chaps youth kid Blue 10 European $60


Child’s Heart Half Chaps youth kid Blue 10 European $60


$30.00


Child's Heart Half Chaps youth kid Pink 10 yr European


Child’s Heart Half Chaps youth kid Pink 10 yr European


$30.00


Child's Heart Half Chaps youth kid Blue 10 European $60


Child’s Heart Half Chaps youth kid Blue 10 European $60


$30.00


NEW Tough-1 Youth Embroidered Half Chaps Small Purple


NEW Tough-1 Youth Embroidered Half Chaps Small Purple


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Medium Purple


NEW Tough-1 Youth Embroidered Half Chaps Medium Purple


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Large Purple


NEW Tough-1 Youth Embroidered Half Chaps Large Purple


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Small Pink


NEW Tough-1 Youth Embroidered Half Chaps Small Pink


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Medium Pink


NEW Tough-1 Youth Embroidered Half Chaps Medium Pink


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Large Pink


NEW Tough-1 Youth Embroidered Half Chaps Large Pink


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Small Blue


NEW Tough-1 Youth Embroidered Half Chaps Small Blue


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Medium Blue


NEW Tough-1 Youth Embroidered Half Chaps Medium Blue


$26.99


NEW Tough-1 Youth Embroidered Half Chaps Large Blue


NEW Tough-1 Youth Embroidered Half Chaps Large Blue


$26.99


Tough-1 Youth Embroidered Half Chaps-Blue-Medium


Tough-1 Youth Embroidered Half Chaps-Blue-Medium


$29.90


Tough-1 Youth Embroidered Half Chaps-Blue-Large


Tough-1 Youth Embroidered Half Chaps-Blue-Large


$29.90


Tough-1 Youth Embroidered Half Chaps-Purple-Large


Tough-1 Youth Embroidered Half Chaps-Purple-Large


$29.90


AN OVERVIEW Progeria: a rare disease CHILD

AN OVERVIEW Progeria: a rare disease CHILD

Kamal Singh Rathore, Sunita P., Khushboo Sharma, RKNema

Â

It is a rare, fatal genetic disease that produces rapid aging, beginning in childhood also known as Hutchinson syndrome € "Gilford Progeria" or "HGPS" and " Hutchinson € "Gilford syndrome" in which symptoms similar to those aspects of aging are manifested at an early age. Progeria was first described by first time in an academic journal by Dr. Jonathan Hutchinson in 1886 and Dr. Hastings Gilford in 1897 – both in England.

 His name is derived from Greek and means "prematurely old." Approximately 1 in 4,000,000 people are diagnosed with this condition. Those born with progeria usually live around 13-20 years, is a genetic disorder that occurs as a new mutation and is not usually inherited, although there is a single heritable. This is often in contrast to another rare premature aging syndrome, but similar, dyskeratosis congenita (DKC), which is inherited and is often expressed in a family line.

Although born looking healthy, children with Progeria begin to display many characteristics of accelerated aging at around 18-24 months of age. Progeria signs include growth failure, loss of body fat and hair, aged-looking skin, stiffness of joints, hip dislocation, generalized atherosclerosis, cardiovascular (heart) and stroke. Children have a remarkable look similar, despite different ethnic backgrounds. Children with Progeria die of the atherosclerosis (heart disease) at a median age of thirteen years (with an interval of approximately 8 to 21 years). According to the Web Hayley's "In Currently there are 53 known cases of Progeria around the world and only 2 in the UK. "There is an incidence of progeria is about 1 of every 4 until 8 million the newly born. Boys and girls are at equal risk of having Progeria.

Symptoms

Progeria is a genetic disorder that causes progressive age children quickly from its first two years of life. The condition is rare, since 1886, only about 130 cases of progeria are been documented in scientific literature. Normally in the first year of life, growth of a child with progeria decreases markedly, so that the height and fall of below average weight for their age and low weight for height falls. Motor development and mental development remain normal.

Signs and symptoms of this progressive disease are:

  • Limited growth or growth failure in the first year of life
  • Narrow, shrunken and wrinkled
  • developmental delay
  • Baldness (Alopecia)
  • Insulin-resistant diabetes (diabetes that does not respond readily to injections insulin)
  • Skin changes similar to that seen in scleroderma (the connective tissue becomes tough and hardened)
  • Loss of eyebrows and eyelashes
  • a distinctive appearance (small face and jaw, pinch the nose)
  • Short stature and small, fragile bodies like those of people elderly
  • Large head for size of face (macrocephaly)
  • Open space soft (fontanelles)
  • Small jaw (micrognathia)
  • Dry, scaly, thin skin
  • Limited range of motion
  • Teeth – delayed formation or absence of
  • Later the condition causes wrinkled skin, atherosclerosis and cardiovascular problems.
  • Slow growth, and below the height and mean weight
  • A small face and nose, which makes the child must be old
  • Head too big for the face
  • Veins prominent scalp
  • Prominent eyes
  • Small lower jaw (micrognathia)
  • Shrilly
  • Delayed and abnormal tooth formation
  • The loss of body fat and muscle
  • Joint stiffness
  • Dislocation hip

Causes

Progeria usually occurs without cause – not seen in siblings of affected children. Extremely rarely more than one child in the same family may have the condition.

It is only very rarely seen in more than one child in a family. Progeria is a disorder of childhood caused by a mutation at position 1824 of the LMNA gene (Lamin A), in substitution of cytosine with thymine, creating useless form of the protein Lamin A. Lamin A is part of the building blocks of the nuclear envelope. 90% of children with progeria have a mutation in the gene that encodes the protein lamin A. a protein that contains the cell's nucleus together. It is believed that the defective Lamin A protein makes the nucleus unstable. This instability seems to lead to premature aging in patients with progeria.

Diagnosis

The diagnosis is suspected according to the signs and symptoms, such as skin changes, abnormal growth, and loss of hair. Can be confirmed through genetic testing. Professional health, possibly Progeria is suspected if signs and symptoms are there – aging of the skin, hair loss, joint stiffness, etc. This may be confirmed through genetic testing. The Progeria Research Foundation has developed a program of diagnostic tests.

No diagnostic test confirms progeria. Doctors usually make a diagnosis based on signs and symptoms, such as lack of growth and hair loss, which generally are not fully evident until your child is almost 2. However, with the discovery of the genetic mutation that causes progeria, it is possible to use genetic testing for mutations LMNA at the first suspicion of progeria. The sooner you know your child has progeria, before your doctor may recommend treatments that help relieve the signs and symptoms of the disease.

A blood test may reveal that your child has a low level of high density lipoprotein (HDL) cholesterol, known as cholesterol good that helps keep arteries open. This finding is not diagnostic laboratory itself but can support a diagnosis of progeria.

Treatment

There are no treatments have proven effective.

  • Most treatment focuses on reducing complications (such as cardiovascular disease) with heart bypass surgery or low-dose aspirin. A daily dose may help prevent heart attacks and stroke brain.
  • Treatment with growth hormone has been tried.
  • Drugs known as farnesyltransferase inhibitors (FTI), which were developed to treat cancer, have shown promise in laboratory studies to correct the defects of cells that cause progeria. FTI are being studied in human clinical trials for the treatment of progeria. Has been proposed, but their use has been mostly limited to animal models. A Phase II clinical trials using the FTI lonafarnib began in May 2007.
  • Physical and occupational therapy. These can help with the stiffness and hip problems, and may allow your child to stay active.
  • The high-calorie diet supplements. Includes calorie daily diet can help your child to prevent weight loss and ensure adequate nutrition.
  • Feeding tube. Babies who are malnourished may benefit from a feeding tube and syringe. You can use the syringe to push the breast milk or formula through the tube to make it easier for your child to feed.
  • Extraction of primary teeth. Your child's permanent teeth start coming in before their teeth fall out. Extraction can help prevent problems associated with the late loss of baby teeth, such as overcrowding and the development of a second row of teeth is when the permanent teeth come

Forecast

There is no known cure. Few people with progeria than 13 years of age. At least 90% of patients die from complications of atherosclerosis, such as heart attack or stroke.

Mental development is not affected. The development of symptoms is comparable to the age at a rate of six to eight times faster than normal, although certain age-related conditions do not occur. Specifically, patients show no neurodegeneration or predisposition cancer. They do not develop physically mediated "wear" conditions commonly associated with aging, such as cataracts (a clouding caused by exposure UV) and osteoarthritis (caused by mechanical wear).

Epidemiology

Hutchinson-Gilford Progeria Syndrome Classic almost never transmitted from father to son. It is usually caused by a new (sporadic) mutation during cell division early in the child. Usually, genetically dominant, therefore, parents who are healthy, they usually do not pass it on to their children. Affected children rarely live long enough to have my own kids.

Research indicates that a chemical (hyaluronic acid) are found at high levels in urine from patients with Hutchinson-Gilford syndrome of progeria. The same abnormality has been found in Werner's syndrome, sometimes called 'progeria of the adult ".

Lamin A

A nuclear lamina is a protein scaffold at the inner edge of the nucleus that helps organize nuclear processes such as synthesis of RNA and DNA.

A pre-laminated Kaax contains a table of the C-terminus of the protein (where C is a cysteine and A is any aliphatic amino acid). This ensures that the cysteine is farnesylated and allows pre-laminated to attach to the membrane, specifically the nuclear membrane. After pre-laminated A has been localized in the nuclear membrane, the C-terminal amino acid including the farnesylated cysteine, are broken out by a specific protease. The result is now protein lamin A is not longer membrane bound, and perform functions within the nucleus.

In 2003, researchers at NHGRI, along with colleagues at the Progeria Research Foundation, the New York State Institute for Basic Research in Developmental Disabilities, and the University of Michigan, discovered that Hutchinson-Gilford progeria is caused by a small dot, a single gene mutation, known as lamin A (LMNA). Parents and siblings of children with progeria almost never affected by the disease. According to this clinical observation, the mutation genetics appears in almost all cases that occur in sperm before conception. It is remarkable that almost all cases was found to arise from the substitution of only a pair of base between the approximately 25,000 DNA base pairs that make up the LMNA gene. The LMNA gene encodes two proteins, Lamin A and Lamin C, which is known to play a key role in stabilizing the inner membrane of the cell nucleus. In laboratory tests with cells taken from progeria patients, researchers have found that mutation responsible for Hutchinson-Gilford progeria causes the LMNA gene to produce an abnormal form of the blade of a protein. It appears that the abnormal protein to destabilize nuclear membrane of the cell in a way that can be particularly harmful to tissues routinely subjected to intense physical force, such as the cardiovascular and musculoskeletal. Interestingly, different mutations in the LMNA gene have shown themselves to be responsible for at least half a dozen other genetic disorders, including two rare forms of muscular dystrophy. In addition to its implications for diagnosis and possible treatment for progeria, the discovery of underlying genetics of this model premature aging may help shed new light on the aging process of normal human beings.

Possible complications

Heart attack (myocardial infarction)

Stroke

How can we help children with progeria?

  • Make a financial contribution. Donations are needed to continue the vital work. Penny No donation is too small or too large â € "each minute counts in our fight for a cure!
  • Donate your time. Volunteers also are important to success. Make a special event like a bake sale or campaign letters, translating documents for families, help with a mailing â € "wea € ™ ll find something for you to do that fits your schedule, location and talent!
  • Donations in kind services or items. Do you own a printer or office supply company? Do you have a background in nonprofit development? These are just some of the many kinds of talents and connections. The more tasks we can get out on a pro bono basis, the more they can spend on research!
  • Spread the word and make connections. Do you know someone who can do any of the above.

Care, coping and support

  • Learning your child has progeria can be emotionally devastating. Suddenly, you know your child is facing many difficult challenges and a shorter life. For you and your family cope with the illness involves a major commitment of physical effort, emotional and financial.
  • When dealing with a condition such as progeria, support groups can be a valuable part of a wider network of social support that includes professionals health, family and friends. In a support group, will be with people who face similar challenges to those who are. Talking with members of the group may help deal with their own feelings about your child's condition. If a group is not for you, talk to a therapist or clergy member may be beneficial.
  • Ask Tell your doctor about self-help groups or therapists in your community. Your local health department, public library, the phone book and the Internet also may be good sources to find a support group in your area.

Help child cope with

  • If your child has progeria, he or she is also likely to feel fear and pain as awareness grows progeria shortens life. The child needs your help to cope with the concept of death and may have a series of difficult but important questions about God and religion. Your child can also ask questions about what will happen in his family after he or she dies.
  • It is critical that you can talk openly and honestly with your child, and provide assurances that supports with their belief system. Ask your doctor, therapist or clergy member to help you prepare for these conversations with your toddler. Friends who known through support groups may also be able to offer valuable guidance.

Conclusion and general discussion

Progeria, or syndrome Hutchinson-Gilford Progeria is a rare and fatal genetic condition of childhood with striking features such aging premature. Children with progeria usually have a normal appearance in early childhood. At approximately nine to 24 months of age, affected children begin to experience profound growth retardation, short stature and low weight. They also develop a distinctive facial appearance characterized by a disproportionately small face in comparison with head, jaw development (micrognathia), malformations and crowding of the teeth abnormally protruding eyes, small nose, bulging eyes and a subtle blueness around the mouth. Moreover, in the second year of life, the scalp hair, eyebrows and eyelashes are lost (alopecia), hair and scalp can be replaced by tiny hairs soft, white or blond. Additional features include generalized atherosclerosis, cardiovascular disease and stroke, hip dislocations, unusually prominent veins in the scalp, loss of the layer of fat under the skin (subcutaneous fat), defects of the nails, joint stiffness, bone defects, and / or other abnormalities. According to reports in the medical literature, individuals with Hutchinson-Gilford syndrome progeria develop premature, widespread thickening and loss of elasticity of arterial walls (atherosclerosis), leading to life-threatening complications during childhood, adolescence or early adulthood. Children with progeria die of heart disease (atherosclerosis) at an average age of 13 years, with a range of about eight to 21 years.

Progeria is caused by a mutation in the gene LMNA, or lamin A. The lamina is a protein scaffolding that holds the nucleus of a cell together. Researchers now believe that the film A defective protein makes the nucleus unstable. That cellular instability appears to lead to premature aging in progeria. Because neither parent carries or expresses the mutation, each case is believed to represent a sporadic, new mutation occurring mainly in a single sperm or egg just before conception.

REFERENCES

  • Ayres, SC, Mihan, R.: Progeria: an approach therapeutic potential. (Letter) JAMA 227: 1381-1382, 1974.
  • Brown, WT: Human mutations affecting aging – a review. Mech. Aging Dev 9: 325-336, 1979.
  • Brown, WT; Abdenur, J.; Goonewardene, P.; Alemzadeh, R. Smith, M., Friedman, S., Cervantes, C., Bandyopadhyay, S.; Zaslav, A.; Kunaporn, S.; Serotkin, A., Lifshitz, F.: Syndrome Hutchinson-Gilford Progeria: clinical abnormalities, chromosomal and metabolic diseases. (Abstract) Am J. Hum. Genet. 47 (Suppl): A50 only, 1990.
  • Brown WT, Darlington GJ: thermolabile enzymes in progeria and Werner's syndrome: evidence contrary to the error hypothesis of the protein. J. Am Hum. Genet. 32: 614-619, 1980.
  • Brown WT, Darlington, GJ, Arnold, A.; Photinus, M.: The detection of HLA antigens on progeria syndrome fibroblasts. Clin. Genet. 17: 213-219, 1980.
  • Cao, H., Hegele RA: LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670), but not in Wiedemann Rautenstrauch progeroid syndrome (MIM 264090). J. Hum. Genet. 48: 271-274, 2003.
  • Dahl, KN, Scaffidi, P., Islam, MF, Yodh, AG, Wilson KL, Misteli, T.: different structural and mechanical properties of the nuclear lamina in Hutchinson-Gilford syndrome progeria. Proc. Acad. Sci 103: 10271-10276, 2006.
  • DeBusk FL: The Hutchinson-Gilford syndrome progeria. J. Pediat. 80: 697-724, 1972.
  • De Martinville, B., Sorin, M., Briard, ML; Frézal, J. Hutchinson-Gilford progeria neonatal debut monozygotes chez des jumeaux. Arch. Fr Pediat. 37: 679-681, 1980.
  • Paula Rodrigues GH, das Eiras Támega, I., Duque, G.; Spinola Dias Neto, V. Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann. Genet. 45: 151-155, 2002.
  • De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio I., Lyonnet, S., Stewart CL, Munnich, A., Le Merre, M., Levy N: Lamin A truncation of Hutchinson-Gilford progeria. Science 300: 2055 only, 2003.
  • Dyck JD, David, TE, Burke, B., Webb GD, Henderson MA, Fowler, RS: Management of coronary artery disease in Hutchinson-Gilford syndrome. J. Pediat. 111: 407-410, 1987.
  • Erecinski, K. Bittel-Dobrzynska, N.; Mostowiec, S. progerii u dwóch Zespol Braci. Pol Tyg. Lek. 16: 806-809, 1961.
  • Eriksson, M. Brown, WT, Gordon LB, Glynn MW, Singer, J. Scott, L., Erdos, MR; Robbins CM, Moses TY, Berglund, P., Dutra, A., Pak, E., Durkin, S., Csoka, AB, Boehnke, M., Glover TW, Collins FS: Recurrent de novo mutations point of lamin A cause Hutchinson-Gilford Progeria Syndrome. Nature 423: 293-298, 2003.
  • Faivre, L., Van Kien, PK; Madinier-Chappat, N.; Nivelon-Chevallier, A., Beer, F.; Lemerre, M.: Can Hutchinson-Gilford progeria syndrome be a neonatal condition? (Letter) J. Genet. 87: 450-452, 1999.
  • Fatunde, DO; Benka-Coker, LBO, Scott-Emuakpor, AB, familial occurrence of progeria syndrome (Hutchinson-Gilford Progeria). (Abstract) Am J. Hum. Genet. 47 (Suppl): A55 only, 1990.
  • Fong, LG, Frost, D., Meta, M., Qiao, X. Yang, SH; COFFINIER, C., Young, SG: A protein farnesyltransferase inhibitor slows disease in a mouse model of progeria. Science 311: 1621-1623, 2006.
  • Gabr, M., Hashem, N. Hashem, M., Fahmi, A.; Safouh, M.: Progeria, pathological study. J. Pediat. 57: 70-77, 1960.
  • Gilford, H. Ateleiosis and progeria: continuous youth and premature aging. Brit Med J. 2: 914-918, 1904.
  • Glynn MW, Glover TW: incomplete treatment of mutant lamina in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum. Molec. Genet. 14: 2959-2969, 2005.
  • Goldman, RD, Shumaker DK, Erdos MR, Eriksson, M., Goldman, AE, Gordon LB, Gruenbaum, Y.; Khuon, S., Mendez, M., Varga, R., Collins, FS: The accumulation of mutant lamina progressive causes changes in nuclear architecture in Hutchinson-Gilford syndrome progeria. Proc. Acad. Sci 101: 8963-8968, 2004.
  • Goldstein, S., Moerman, EJ: Heat-labile enzymes in skin fibroblasts from patients with progeria. New Eng J Med 292: 1305-1309, 1975.
  • Goldstein, S., Moerman, EJ: Heat-labile enzymes in circulating erythrocytes of a progeria family. J. Am Hum. Genet. 30: 167-173, 1978.
  • Harley, CB, Goldstein, S., Posner, BI; Guydo, H.: Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with activity insulinlike. J. Clin. Invest. 68: 988-994, 1981.
  • Hennekam, RCM's syndrome Hutchinson-Gilford Progeria: a review of the phenotype. J. Genet. 140A: 2603-2624, 2006.
  • Hutchinson, J.: A case of congenital absence of hair, with atrophic condition of skin and its appendages, in a child whose mother had been almost totally bald from alopecia areata from the age of six. Lancet I: only 923, 1886.
  • Jones, KL, Smith DW, Harvey MAS, Hall BD, Quan, L.: age of older parents and fresh gene mutation: data on additional disorders. J. Pediat. 86: 84-88, 1975.
  • Khalifa, MM: Hutchinson-Gilford Progeria syndrome: report of a Libyan family and evidence of autosomal recessive inheritance. Clin. Genet. 35: 125-132, 1989.
  • Kirschner, J., Brune, T.; Wehnert, M., Denecke, J., Wasner C., Feuer, A., Marquardt, T. Ketelsen, U.-P.; Wieacker, P.; Bonnemann, CG; Korinthenberg, R. p.S143F mutation in the lamin A / C: a new phenotype combining myopathy and progeria. Ann. Neurol. 57: 148-151, 2005.
  • Labeille, B. Dupuy, P., Frey-Follezou, I.; Larregue, M.; Maquart, FX, Borel JP, Gallet, M.; Risbourg, B.; Denceux, JP Hutchinson-Gilford progeria Neonatale cutanee sclerodermiforme avec atteinte. Ann. Derm. Venerol. 114: 233-242, 1987.
  • Lewis, M. : PRELP, collagen, and a theory of Hutchinson-Gilford Progeria. Aging Res Rev 2: 95-105, 2003.
  • Luengo WD, Martinez, AR, Lopez, RO; Basalo CM, Rojas-Atencio, A., Quintero, M.; Borjas, L., Morales-Machin, A. Foster, SG; Bernal, LP; Canizalez-Tarazona, J., Pena, J., Luengo, JD Hernandez, JC Chang, JC: Del (1) (q23) in a patient with Hutchinson-Gilford progeria. J. Genet. 113: 298-301, 2002.
  • Maciel, HS: Evidence for autosomal recessive inheritance of progeria (Hutchinson Gilford). J. Genet. 31: 483-487, 1988.
  • Mallampalli, MP, Huyer, G.; Bendala, P., Gelb MH, Michaelis, S. : Inhibition farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford syndrome progeria. Proc. Acad. Sci 102: 14416-14421, 2005.
  • McKusick, VA: Clinical observations of Jonathan Hutchinson. J. Syph. 36: 101-126, 1952.
  • Merideth MA, Gordon LB, Clauss, S.; Sachdev, V., Smith, A. CM, Perry, MB, Brewer CC, Zalewski, C. Kim, HJ, and 13 others: Gilford syndrome phenotype and course of Hutchinson-progeria. New Eng J. Med 358: 592-604, 2008.
  • Moulton, CL, Fong LG, Gardner JM, Farber EA, Go, G. Passariello, A., Grange DK, Young SG, Miner JH: progerin Increased expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum. Mutat. 28: 882-889, 2007.
  • Ogihara, T., Hata, T. Tanaka, K., Fukuchi, K., Tabuchi, Y. Kumah, Y. syndrome, Hutchinson-Gilford Progeria in a 45-year-old man. J. Med 81: 135-138, 1986.
  • Parkash, H., Sidhu, SS Raghavan, R. Deshmukh, RN: Hutchinson-Gilford Progeria: family history. J. Genet. 36: 431-433, 1990.
  • Plasilova, M., Chattopadhyay, C., Pal, P., Schaub, NA, Buechner SA, Mueller, H., Miny, P., Garcia, A. Heinemann, K.: homozygous nonsense mutation in the lamin A / C gene causes autosomal recessive Hutchinson-Gilford Progeria syndrome. J. Genet. 41: 609-614, 2004.
  • Rautenstrauch, T.; Snigula, F., Krieg, T., Gay, S., Muller, PK: Progeria: a culture study cellular and clinical report of a familial incidence. Europ. J. Pediat. 124: 101-112, 1977.
  • Rava, G.: Its a nucleo familiare di progeria. Minerva Med 58: 1502-1509, 1967.
  • Rodriguez, JI, Perez-Alonso, P.: The diagnosis of progeria syndrome is the only possible one. (Letter) J. Genet. 87: 453-454, 1999.
  • Rodriguez, JI, Perez-Alonso, P., Funes, R., Perez-Rodriguez, J.: Lethal neonatal syndrome, Hutchinson Gilford Progeria. J. Genet. 82: 242-248, 1999.
  • Sagelius, H.; Rosengardten, Y., Schmidt, E.; Sonnabend, C., Rozell, B., Eriksson, M.: Reversible phenotype in a model of mouse syndrome Hutchinson-Gilford Progeria. J. Genet. 45: 794-801, 2008.
  • Varela, I., Pereira, S., Ugalde, AP, Navarro, CL, Suarez, MF; Cau, P.; Cadiñanos, J., Osorio, FG, Foray, N., Cobo, J. Charles, F., Levy, N., Freije, JMP, Lopez-Otin, C.: Combination therapy with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. (Letter) Nature Med 14: 767-772, 2008.
  • Viegas, J., Souza, PLR, Salzano, FM: Progeria in twins. J. Genet. 11: 384-386, 1974.
  • Wang, J. Robinson JF, O'Neil CH, Edwards JY, Williams CM, Huff, MW; Pickering JG, Hegele, RA: Overexpression of ankyrin G in the syndrome of Hutchinson-Gilford Progeria fibroblasts identified through biological filtering profiles expression. J. Hum. Genet. 51: 934-942, 2006.
  • Wuyts, W.; Biervliet, M., Reyniers, E., D'Apice MR, Novelli, G., Storm, K.: Somatic and gonadal mosaicism in Hutchinson-Gilford progeria. J. Genet. 135A: 66-68, 2005.
  • Yang, SH, Meta, M., Qiao, X., Frost, D., Bauch, J.; COFFINIER, C., Majumdar, S., Bergo, MO, Young, SG, Fong, LG: A farnesyltransferase inhibitor improves disease phenotypes in mice with Hutchinson-Gilford syndrome progeria mutation. J. Clin. Invest. 116: 2115-2121, 2006.
  • Brown WT. Progeria. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, Pa: WB Saunders, 2007: chap 90.
  • Learn about progeria. National Institute of Genome Research. http://www.genome.gov/11007255. Accessed March 5, 2009.
  • Progeria. National Institutes of Health. http://www.nih.gov/about/researchresultsforthepublic/Progeria.pdf. Accessed March 5, 2009.
  • Progeria (syndrome Hutchinson-Gilford). The Merck Manuals Online Medical Library: The Merck Manual for health professionals. http://www.merck.com/mmpe/sec19/ch286/ch286d.html. Accessed March 5, 2009.
  • Brown TW. Progeria. In: Kliegman RM, et al. Kliegman: Nelson Textbook of Pediatrics. 18th ed. Elsevier Saunders, 2007. http://www.mdconsult.com/book/player/book.do?method=display&type=bookPage&decorator=header&eid=4-u1.0-B978-1-4160-2450-7..50092-X&uniq=124224571&isbn=978 -1-4160-2450-7 & Sid = 812,951,456. Accessed March 5, 2009.
  • Brown TW. Hutchinson-Gilford syndrome progeria. National Institutes of Health: Gene Reviews. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hgps. Accessed March 5, 2009.
  • Syndrome Hutchinson-Gilford progeria. Genetics Home Reference. http://ghr.nlm.nih.gov/condition=hutchinsongilfordprogeriasyndrome. Accessed March 5, 2009.
  • Cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder. Institutes National Health. http://www.nih.gov/news/health/oct2008/nhgri-06.htm. Accessed March 5, 2009.
  • Martini R. Helping kids face chronic illness. American Academy of Child and Adolescent Psychiatry. Accessed March 5, 2009.
  • Paterson, D.: A case of progeria. Proc. Roy. Soc Med 16: 42 only in 1922.
  • Brown, WT Personal communication. Staten Island, NY, 1/12/2004.

Support Groups

Progeria Research Foundation, Inc. – www.progeriaresearch.org

About the Author

Reader, Bhupal Nobles’ Girls’ College of Pharmacy, Udaipur-Raj.313002 INDIA
Email: kamalsrathore@yahoo.com
kamalsrathore@gmail.com
Mobile: +919828325713

FOR SALE

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay

Leave a Reply

»  Substance: WordPress   »  Style: Ahren Ahimsa